Publicação
Diabetic Ketoacidosis Precipitated by COVID-19
| Resumo: | COVID-19 has a broad spectrum of presentation, ranging from asymptomatic to severe disease. Patients with comorbidities, such as cardiovascular and metabolic, have a higher risk of developing severe disease or even complications. COVID-19 may precipitate the onset of metabolic complications such as diabetic ketoacidosis. There have been reported cases of mild or even asymptomatic disease associated with states of ketoacidosis, and the virus may act as a precipitating factor for metabolic deterioration even in the absence of symptoms. Therefore, further clinical studies are imperative to understand the correlation between COVID-19 and diabetic ketoacidosis. |
|---|---|
| Autores principais: | Barros, Carolina |
| Outros Autores: | Malheiro, Alexandra; Martins, Mariana; Correia, João Paulo; Perneta Santos, Miguel; Balza, Pedro |
| Assunto: | COVID-19 Cetoacidose Diabética SARS-CoV-2 COVID-19 Diabetic Ketoacidosis SARS-CoV-2 |
| Ano: | 2021 |
| País: | Portugal |
| Tipo de documento: | artigo |
| Tipo de acesso: | unknown |
| Instituição associada: | CUF |
| Idioma: | português |
| Origem: | Gazeta Médica |
| Resumo: | COVID-19 has a broad spectrum of presentation, ranging from asymptomatic to severe disease. Patients with comorbidities, such as cardiovascular and metabolic, have a higher risk of developing severe disease or even complications. COVID-19 may precipitate the onset of metabolic complications such as diabetic ketoacidosis. There have been reported cases of mild or even asymptomatic disease associated with states of ketoacidosis, and the virus may act as a precipitating factor for metabolic deterioration even in the absence of symptoms. Therefore, further clinical studies are imperative to understand the correlation between COVID-19 and diabetic ketoacidosis. |
|---|